Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (181)

Advertisement

Research Article Free access | 10.1172/JCI115842

Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension.

G Lembo, R Napoli, B Capaldo, V Rendina, G Iaccarino, M Volpe, B Trimarco, and L Saccà

Department of Internal Medicine, II School of Medicine, Federico II University, Napoli, Italy.

Find articles by Lembo, G. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, II School of Medicine, Federico II University, Napoli, Italy.

Find articles by Napoli, R. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, II School of Medicine, Federico II University, Napoli, Italy.

Find articles by Capaldo, B. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, II School of Medicine, Federico II University, Napoli, Italy.

Find articles by Rendina, V. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, II School of Medicine, Federico II University, Napoli, Italy.

Find articles by Iaccarino, G. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, II School of Medicine, Federico II University, Napoli, Italy.

Find articles by Volpe, M. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, II School of Medicine, Federico II University, Napoli, Italy.

Find articles by Trimarco, B. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, II School of Medicine, Federico II University, Napoli, Italy.

Find articles by Saccà, L. in: JCI | PubMed | Google Scholar

Published July 1, 1992 - More info

Published in Volume 90, Issue 1 on July 1, 1992
J Clin Invest. 1992;90(1):24–29. https://doi.org/10.1172/JCI115842.
© 1992 The American Society for Clinical Investigation
Published July 1, 1992 - Version history
View PDF
Abstract

The reason why hyperinsulinemia is associated with essential hypertension is not known. To test the hypothesis of a pathophysiologic link mediated by the sympathetic nervous system, we measured the changes in forearm norepinephrine release, by using the forearm perfusion technique in conjunction with the infusion of tritiated NE, in patients with essential hypertension and in normal subjects receiving insulin intravenously (1 mU/kg per min) while maintaining euglycemia. Hyperinsulinemia (50-60 microU/ml in the deep forearm vein) evoked a significant increase in forearm NE release in both groups of subjects. However, the response of hypertensives was threefold greater compared to that of normotensives (2.28 +/- 45 ng.liter-1.min-1 in hypertensives and 0.80 +/- 0.27 ng.liter-1 in normals; P less than 0.01). Forearm glucose uptake rose to 5.1 +/- .7 mg.liter-1.min-1 in response to insulin in hypertensives and to 7.9 +/- 1.3 mg.liter-1.min-1 in normotensives (P less than 0.05). To clarify whether insulin action was due to a direct effect on muscle NE metabolism, in another set of experiments insulin was infused locally into the brachial artery to expose only the forearm tissues to the same insulin levels as in the systemic studies. During local hyperinsulinemia, forearm NE release remained virtually unchanged both in hypertensive and in normal subjects. Furthermore, forearm glucose disposal was activated to a similar extent in both groups (5.0 +/- 0.6 and 5.2 +/- 1.1 mg.liter-1.min-1 in hypertensives and in normals, respectively). These data demonstrate that: (a) insulin evokes an abnormal muscle sympathetic overactivity in essential hypertension which is mediated by mechanisms involving the central nervous system; and (b) insulin resistance associated with hypertension is demonstrable in the skeletal muscle tissue only with systemic insulin administration which produces muscle sympathetic overactivity. The data fit the hypothesis that the sympathetic system mediates the pathophysiologic link between hyperinsulinemia and essential hypertension.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 24
page 24
icon of scanned page 25
page 25
icon of scanned page 26
page 26
icon of scanned page 27
page 27
icon of scanned page 28
page 28
icon of scanned page 29
page 29
Version history
  • Version 1 (July 1, 1992): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (181)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts